C57BL/6JCya-Plpp4em1/Cya
Common Name
Plpp4-KO
Product ID
S-KO-09827
Backgroud
C57BL/6JCya
Strain ID
KOCMP-381925-Plpp4-B6J-VA
Status
When using this mouse strain in a publication, please cite “Plpp4-KO Mouse (Catalog S-KO-09827) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
Basic Information
Strain Name
Plpp4-KO
Strain ID
KOCMP-381925-Plpp4-B6J-VA
Gene Name
Product ID
S-KO-09827
Gene Alias
Gm1090, Ppapdc1a, C030048B12Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 7
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000094018
NCBI RefSeq
NM_001080963
Target Region
Exon 2~5
Size of Effective Region
~17.1 kb
Overview of Gene Research
PLPP4, also known as PPAPDC1A, is a phospholipid phosphatase enzyme involved in the regulation of triacylglycerol metabolism [3]. It may play significant roles in multiple biological processes, and its study in genetic models can help uncover its functions.
In various cancers, PLPP4 has been implicated. In breast cancer, its up-regulation is observed, and knockdown of PLPP4 suppresses cell proliferation, migration, invasion, enhances apoptosis, and improves sensitivity to doxorubicin (DOX). The transcription factor CAPRIN1 can transcriptionally activate PLPP4 to promote breast cancer progression and inhibit DOX sensitivity [1]. In glioma and pancreatic adenocarcinoma, high expression of PLPP4 is associated with poor clinicopathological features and overall survival, and silencing PLPP4 inhibits cell proliferation, invasion, and migration [2]. In lung carcinoma, high PLPP4 expression correlates with poor clinicopathological features and survival, and silencing PLPP4 inhibits proliferation, cell cycle progression, and tumorigenesis, potentially via reducing intracellular Ca2+ influx [4].
In conclusion, PLPP4 is a key gene in lipid metabolism-related processes. Through gene-knockout or knockdown studies in cancer cells, it has been shown to play important roles in promoting the progression of breast, glioma, pancreatic, and lung cancers. Understanding PLPP4's functions may offer new therapeutic strategies for these cancer types.
References:
1. Yuan, Xiaorong, Yang, Xuejie. 2024. CAPRIN1 Transcriptionally Activated PLPP4 to Inhibit DOX Sensitivity and Promote Breast Cancer Progression. In Cell biochemistry and biophysics, , . doi:10.1007/s12013-024-01614-0. https://pubmed.ncbi.nlm.nih.gov/39556159/
2. Tian, Wenxiu, Wang, Ping, Wang, Zhimei, Dong, Junhong, Wang, Hongmei. 2021. Phospholipid Phosphatase 4 as a Driver of Malignant Glioma and Pancreatic Adenocarcinoma. In Frontiers in oncology, 11, 790676. doi:10.3389/fonc.2021.790676. https://pubmed.ncbi.nlm.nih.gov/34917513/
3. Soni, Sneha, Makwana, Sweta H, Bansal, Shivani, Kumari, Monika, Mandal, Chandi C. 2025. Lipid metabolism associated PLPP4 gene drives oncogenic and adipogenic potential in breast cancer cells. In Biochimica et biophysica acta. Molecular and cell biology of lipids, 1870, 159609. doi:10.1016/j.bbalip.2025.159609. https://pubmed.ncbi.nlm.nih.gov/40187483/
4. Zhang, Xin, Zhang, Lan, Lin, Bihua, Ren, Dong, Huang, Yanming. 2017. Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells. In Molecular cancer, 16, 147. doi:10.1186/s12943-017-0717-5. https://pubmed.ncbi.nlm.nih.gov/28851360/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
